Penserra Capital Management LLC lowered its stake in shares of FIGS, Inc. (NYSE:FIGS - Free Report) by 7.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 652,130 shares of the company's stock after selling 51,144 shares during the quarter. Penserra Capital Management LLC owned approximately 0.40% of FIGS worth $2,993,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in FIGS. MetLife Investment Management LLC boosted its holdings in FIGS by 3.1% in the fourth quarter. MetLife Investment Management LLC now owns 78,952 shares of the company's stock worth $489,000 after purchasing an additional 2,355 shares during the period. Malaga Cove Capital LLC boosted its holdings in shares of FIGS by 1.2% in the 4th quarter. Malaga Cove Capital LLC now owns 216,669 shares of the company's stock valued at $1,341,000 after buying an additional 2,547 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in shares of FIGS by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 73,943 shares of the company's stock valued at $458,000 after buying an additional 2,807 shares during the period. Invesco Ltd. boosted its position in FIGS by 2.7% during the 4th quarter. Invesco Ltd. now owns 145,734 shares of the company's stock valued at $902,000 after purchasing an additional 3,879 shares during the period. Finally, GAMMA Investing LLC boosted its holdings in shares of FIGS by 585.8% during the first quarter. GAMMA Investing LLC now owns 6,536 shares of the company's stock valued at $30,000 after acquiring an additional 5,583 shares during the period. 92.21% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research analysts have issued reports on the stock. The Goldman Sachs Group reduced their target price on shares of FIGS from $4.25 to $3.75 and set a "sell" rating for the company in a research note on Tuesday, April 22nd. Morgan Stanley reduced their price objective on FIGS from $4.75 to $4.25 and set an "equal weight" rating for the company in a research report on Thursday, April 17th. Barclays reiterated a "positive" rating on shares of FIGS in a research report on Tuesday, May 13th. Finally, Telsey Advisory Group reiterated a "market perform" rating and set a $5.00 price target on shares of FIGS in a research report on Tuesday, May 13th.
Read Our Latest Research Report on FIGS
FIGS Stock Performance
Shares of FIGS stock traded down $0.17 during midday trading on Friday, reaching $6.00. 2,143,159 shares of the company were exchanged, compared to its average volume of 2,623,667. FIGS, Inc. has a 12 month low of $3.57 and a 12 month high of $7.06. The company has a market cap of $974.49 million, a P/E ratio of 600.10 and a beta of 1.32. The company's 50 day moving average price is $5.10 and its two-hundred day moving average price is $5.05.
FIGS Company Profile
(
Free Report)
FIGS, Inc operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel.
Featured Articles

Before you consider FIGS, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and FIGS wasn't on the list.
While FIGS currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.